A pap smear, also called a Pap test, is a routine screening procedure that examines cells from the cervix for abnormal changes that could indicate precancer or early cancer. This simple test plays a critical role in women’s health by enabling early detection and prevention of cervical cancer before serious problems develop.
Regular screening tailored to your age and risk profile helps people and clinicians make informed decisions about follow-up care and preventive treatment. Understanding what the procedure involves, how often it is needed, and what abnormal results mean supports clearer communication with your provider.
| Aspect | What It Is | Clinical Purpose | Typical Outcome |
|---|---|---|---|
| Definition | Collection of cervical cells using a soft brush and spatula during a pelvic exam | Screen for abnormal cell changes linked to HPV infection | Normal cells, ASC-US, LSIL, HSIL, or invasive cancer |
| Age to Start | Generally at age 21, regardless of sexual activity | Detect early changes when they are most treatable | Baseline screening in the early twenties |
| Frequency | Every 3 years for ages 21–65 if results are normal; or every 5 years with an HPV co-test starting at 30 | Balance early detection with avoiding unnecessary procedures | Continued screening, reflex HPV testing, or colposcopy |
| Follow-up for Abnormal Results | Repeat Pap, HPV testing, or referral for colposcopy with biopsy | Determine whether abnormal cells are high grade and need treatment | Observation, minor procedures, or rarely more extensive care |
Understanding How a Pap Smear Works
What Happens During the Test
A pap smear is performed during a pelvic exam, often alongside a clinical breast exam and discussion of sexual or reproductive health. After positioning on the exam table with a speculum to visualize the cervix, a healthcare provider uses a small brush or spatula to gently collect cells from the cervix surface and canal. You may feel brief pressure or mild cramping, but the procedure typically takes only one to two minutes.
How Cells Are Analyzed
In the lab, a cytotechnologist or pathologist examines the cells under a microscope to identify changes in size, shape, or organization that may signal infection, inflammation, low-grade abnormalities, or high-grade lesions. The Bethesda System categorizes results with clear descriptors such as negative for intraepithelial lesion or malignancy, atypical squamous cells of undetermined significance (ASC-US), low-grade or high-grade squamous intraepithelial lesion (LSIL or HSIL), and glandular abnormalities. These standardized reports help clinicians decide whether additional testing or treatment is necessary.
Who Should Be Screened and When
Guidelines by Age and Risk
Major health organizations recommend that screening typically begins at age 21 and that people aged 21 to 29 have a Pap test alone every three years. People aged 30 to 65 may choose a Pap test every three years, an HPV test every five years, or a combination co-test every five years. Screening may stop after age 65 only when past screening is adequate and risk is low, and people with a history of cervical cancer, DES exposure, or a weakened immune system may need more frequent or earlier screening.
Special Situations
Those who have had a total hysterectomy for benign reasons, are vaccinated against HPV, or have HIV or prior abnormal results often follow individualized plans rather than routine schedules. In these cases, closer monitoring or longer screening intervals may be recommended, and decisions should be made jointly with a clinician to align with personal medical history and preferences.
Interpreting Results and Next Steps
Understanding the Report
Receiving a result such as ASC-US or LSIL can feel confusing, but many findings reflect temporary HPV-related changes that resolve on their own. High-grade abnormalities may prompt a colposcopy, where a magnified exam of the cervix is combined with targeted biopsies to guide decisions about treatment. Your clinician will explain what each result means in practical terms and outline clear options for monitoring or care.
Follow-up and Prevention
Depending on the result, recommendations may include repeating the Pap in a year, doing HPV testing, or referring you to a specialist for further evaluation. This tiered approach helps people avoid overtreatment while ensuring that higher-grade issues are addressed promptly. Consistent follow-up and open communication with your provider improve outcomes and reduce uncertainty after an abnormal result.
Key Takeaways and Practical Tips
- Begin screening at age 21 and follow age-based intervals to detect changes early.
- Understand your results and ask your provider to explain any abnormal findings in clear language.
- Use HPV co-testing when appropriate to extend screening intervals and improve detection.
- Maintain open communication about symptoms, sexual history, and vaccine records with your clinician.
- Keep a record of past results and adhere to recommended follow-up to ensure timely care.
FAQ
Reader questions
How often do I need a Pap smear if I am in my 30s and my results have always been normal?
You may have a Pap test every three years, or choose HPV co-testing every five years, based on shared decision-making with your clinician, your medical history, and current guidelines.
I received an ASC-US result; does this mean I have an infection or cancer?
No, ASC-US typically indicates minor cellular changes most often related to HPV; it commonly leads to HPV testing or a repeat Pap rather than immediate treatment.
Does a Pap smear check for sexually transmitted infections or ovarian cancer?
A Pap smear screens for cervical cell changes; it does not diagnose STIs or ovarian cancer, though HPV testing may be done alongside to refine risk assessment.
I received the HPV vaccine; do I still need regular Pap smears?
Yes, vaccination greatly reduces but does not eliminate risk, so ongoing screening according to your age and risk profile is still essential.